Quantum Genomics

ALQGC

FR0011648971

Biotechnology & Medical Research

Market Closed - Euronext Paris Other stock markets 11:25:15 2024-04-26 am EDT			5-day change	1st Jan Change
0.1292 ^EUR	+1.89%		+9.86%	+21.89%

Mar. 13	Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	CI

Quantum Genomics Société Anonyme(ENXTPA:ALQGC) dropped from S&P Global BMI Index

September 19, 2022 at 12:00 am EDT

Latest news about Quantum Genomics

Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 12	CI
Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-24	CI
Quantum Genomics: negotiations with Vistacare terminated	23-10-18	CF
Global markets live: Microsoft, Raytheon, JPMorgan, Credit Suisse...	23-05-26
Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-26	CI
Quantum Genomics: advanced discussions with a partner	23-04-06	CF
Quantum Genomics Ousts Board President; CEO Named Successor	23-02-23	MT
Quantum Genomics' Hypertension Drug Firibastat Fails to Show Significant Efficacy in Late-Stage Trial	22-10-28	MT
Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, Fresh and Is Redirecting to New Developments	22-10-28	CI
Certain Shares of Quantum Genomics Société Anonyme are subject to a Lock-Up Agreement Ending on 24-OCT-2022.	22-10-23	CI
Quantum Genomics Société Anonyme Reports Earnings Results for the Half Year Ended June 30, 2022	22-10-05	CI
Quantum Genomics Société Anonyme(ENXTPA:ALQGC) dropped from S&P Global BMI Index	22-09-19	CI
Quantum Genomics Announces the Appointment of Its New Scientific Advisory Board	22-06-27	CI
Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH	22-05-09	CI
Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs	22-05-04	CI
Quantum Genomics Société Anonyme Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-28	CI
Quantum Genomics Société Anonyme announced that it expects to receive €15 million in funding from Otium Capital, Vatel Capital SAS	22-04-25	CI
Quantum Genomics Announces Publication of a New Scientific Article Featuring QGC606	22-03-31	CI
Quantum Genomics Secures New Patents For Potential Heart Drug QGC606	22-03-29	MT
Quantum Genomics Announces Granting of New Patents Protecting QGC606	22-03-28	CI
Stéphane Cohen Joins Quantum Genomics as Director of Global Operations	22-03-14	CI
Quantum Genomics Société Anonyme Signs an Exclusive License and Production Agreement with Julphar	21-12-06	CI
Quantum Genomics Société Anonyme announced that it expects to receive $2 million in funding from Gulf Pharmaceutical Industries P.S.C.	21-12-05	CI
Quantum Genomics Signs an Exclusive License Agreement with Teva Israel Ltd	21-11-25	CI
Quantum Genomics : Starts Late-Stage Study For Hypertension Treatment In Asia	21-10-08	MT

Quantum Genomics is a biotechnology company that specializes in the research and development of drugs for the treatment of cardiovascular diseases such as high blood pressure and heart failure. All sales are abroad.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

SELL

Number of Analysts

Last Close Price

0.1292 EUR

Average target price

0.1 EUR

Spread / Average Target

-22.60%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
QUANTUM GENOMICS	+21.89%	4.81M
IQVIA HOLDINGS INC.	+1.51%	42.75B
MODERNA, INC.	+8.57%	41.34B
LONZA GROUP AG	+49.22%	41.61B
CELLTRION, INC.	-12.36%	26.59B
ICON PUBLIC LIMITED COMPANY	+8.92%	25.49B
ALNYLAM PHARMACEUTICALS, INC.	-25.13%	18.12B
MEDPACE HOLDINGS, INC.	+29.17%	12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3.12%	11.76B
UNITED THERAPEUTICS CORPORATION	+6.35%	11B

Other Biotechnology & Medical Research

Quantum Genomics

Equities

ALQGC

FR0011648971

Biotechnology & Medical Research

Quantum Genomics Société Anonyme(ENXTPA:ALQGC) dropped from S&P Global BMI Index

Latest news about Quantum Genomics

Chart Quantum Genomics

Company Profile

Income Statement Evolution

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research